G
GlucoTrack, Inc. (GCTK)
NCM – Real Time Price. Currency in USD
0.74
-0.03 (-4.29%)
At close: May 12, 2026, 4:00 PM EDT
0.72
-0.02 (-2.49%)
After-hours: May 12, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.74
-0.03 (-4.29%)
At close: May 12, 2026, 4:00 PM EDT
0.72
-0.02 (-2.49%)
After-hours: May 12, 2026, 7:58 PM EDT
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
| Name | Position |
|---|---|
| Dr. Mark Tapsak Ph.D. | Chief Scientific Officer |
| Dr. Paul V. Goode Ph.D. | CEO, President & Director |
| Mr. Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board |
| Mr. David Malka BA | Co-Founder |
| Mr. Vincent Wong | Chief Operations Officer |
| Ms. Drinda Benjamin | Vice President of Marketing |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | form8-k.htm |
| 2026-04-30 | 8-K | form8-k.htm |
| 2026-04-29 | POS AM | formposam.htm |
| 2026-04-14 | 8-K | form8-k.htm |
| 2026-03-30 | 8-K | form8-k.htm |
| 2026-03-27 | 8-K | form8-k.htm |
| 2026-03-13 | 8-K | form8-k.htm |
| 2026-02-09 | DEF 14A | formdef14a.htm |
| 2026-01-29 | PRE 14A | formpre14a.htm |
| 2026-01-23 | CORRESP | filename1.htm |